BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19827098)

  • 1. New binary solid dispersion of indomethacin with surfactant polymer: from physical characterization to in vitro dissolution enhancement.
    Sivert A; Bérard V; Andrès C
    J Pharm Sci; 2010 Mar; 99(3):1399-413. PubMed ID: 19827098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
    Sun DD; Ju TC; Lee PI
    Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and stability of solid dispersions based on PEG/polymer blends.
    Bley H; Fussnegger B; Bodmeier R
    Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.
    Prasad D; Chauhan H; Atef E
    J Pharm Sci; 2014 Nov; 103(11):3511-3523. PubMed ID: 25196860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions.
    Andrews GP; AbuDiak OA; Jones DS
    J Pharm Sci; 2010 Mar; 99(3):1322-35. PubMed ID: 19798757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymer incorporation method affects the physical stability of amorphous indomethacin in aqueous suspension.
    Surwase SA; Itkonen L; Aaltonen J; Saville D; Rades T; Peltonen L; Strachan CJ
    Eur J Pharm Biopharm; 2015 Oct; 96():32-43. PubMed ID: 26092472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient approach to enhance drug solubility by particle engineering of bovine serum albumin.
    Khoder M; Abdelkader H; ElShaer A; Karam A; Najlah M; Alany RG
    Int J Pharm; 2016 Dec; 515(1-2):740-748. PubMed ID: 27832954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-step continuous extrusion process for the manufacturing of solid dispersions.
    Maniruzzaman M; Nair A; Scoutaris N; Bradley MS; Snowden MJ; Douroumis D
    Int J Pharm; 2015 Dec; 496(1):42-51. PubMed ID: 26403386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of film-casting technique to investigate drug-polymer miscibility in solid dispersion and hot-melt extrudate.
    Parikh T; Gupta SS; Meena AK; Vitez I; Mahajan N; Serajuddin AT
    J Pharm Sci; 2015 Jul; 104(7):2142-52. PubMed ID: 25917333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interdependence of particle properties and bulk powder behavior of indomethacin in quench-cooled molten two-phase solid dispersions.
    Semjonov K; Salm M; Lipiäinen T; Kogermann K; Lust A; Laidmäe I; Antikainen O; Strachan CJ; Ehlers H; Yliruusi J; Heinämäki J
    Int J Pharm; 2018 Apr; 541(1-2):188-197. PubMed ID: 29481945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Polymer/Surfactant as Carriers on the Solubility and Dissolution of Fenofibrate Solid Dispersion.
    Yang B; Wu L; Ke J; Zhou L; Chen M; Li S; Feng X
    AAPS PharmSciTech; 2019 Feb; 20(3):102. PubMed ID: 30723877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the use of spray congealing to produce solid dispersions with enhanced indomethacin bioavailability: In vitro characterization and in vivo study.
    Bertoni S; Albertini B; Ferraro L; Beggiato S; Dalpiaz A; Passerini N
    Eur J Pharm Biopharm; 2019 Jun; 139():132-141. PubMed ID: 30910731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of HPMC based polymers performance as carriers for manufacture of solid dispersions using the melt extruder.
    Ghosh I; Snyder J; Vippagunta R; Alvine M; Vakil R; Tong WQ; Vippagunta S
    Int J Pharm; 2011 Oct; 419(1-2):12-9. PubMed ID: 21782911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques.
    Meng F; Gala U; Chauhan H
    Drug Dev Ind Pharm; 2015; 41(9):1401-15. PubMed ID: 25853292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-Smectite Clay Amorphous Solid Dispersions Processed by Hot Melt Extrusion.
    Nandi U; Mithu MSH; Hurt AP; Trivedi V; Douroumis D
    AAPS PharmSciTech; 2020 Oct; 21(7):276. PubMed ID: 33033890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical stability of solid dispersions with respect to thermodynamic solubility of tadalafil in PVP-VA.
    Wlodarski K; Sawicki W; Kozyra A; Tajber L
    Eur J Pharm Biopharm; 2015 Oct; 96():237-46. PubMed ID: 26247119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application and functional characterization of POVACOAT, a hydrophilic co-polymer poly(vinyl alcohol/acrylic acid/methyl methacrylate) as a hot-melt extrusion carrier.
    Xu M; Zhang C; Luo Y; Xu L; Tao X; Wang Y; He H; Tang X
    Drug Dev Ind Pharm; 2014 Jan; 40(1):126-35. PubMed ID: 23336809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utilization of drug-polymer interactions for improving the chemical stability of hot-melt extruded solid dispersions.
    Guo Z; Lu M; Li Y; Pang H; Lin L; Liu X; Wu C
    J Pharm Pharmacol; 2014 Feb; 66(2):285-96. PubMed ID: 24433427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism of Indomethacin in Semicrystalline Dispersions: Formation, Transformation, and Segregation.
    Van Duong T; Lüdeker D; Van Bockstal PJ; De Beer T; Van Humbeeck J; Van den Mooter G
    Mol Pharm; 2018 Mar; 15(3):1037-1051. PubMed ID: 29307188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of prednisone:polyethylene glycol 6000 fast-release tablets from solid dispersions: solid-state characterization, dissolution behavior, and formulation parameters.
    Leonardi D; Barrera MG; Lamas MC; Salomón CJ
    AAPS PharmSciTech; 2007 Dec; 8(4):E108. PubMed ID: 18181529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.